Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andra Balanescu

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|May 17, 2012
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trialPaul P Tak, Andra Balanescu, Vira Tseluyko, et al.
European Journal of Rheumatology|October 7, 2016
Low vitamin D status in systemic sclerosis and the impact on disease phenotypeLaura Groseanu, Violeta Bojinca, Tania Gudu, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Arthritis Care & Research|January 22, 2020
Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Maarten de Wit, et al.
Arthritis Research & Therapy|November 29, 2025
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trialsLaure Gossec, Andra Balanescu, Maria Antonietta D'Agostino, et al.
Rheumatology (Oxford, England)|July 24, 2020
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trialJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Maedica|May 4, 2017
Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma PatientsLaura Groseanu, Florian Berghea, Andra Balanescu, et al.
Maedica|May 4, 2017
Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma PatientsLaura Groseanu, Florian Berghea, Andra Balanescu, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|May 17, 2012
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trialPaul P Tak, Andra Balanescu, Vira Tseluyko, et al.
European Journal of Rheumatology|October 7, 2016
Low vitamin D status in systemic sclerosis and the impact on disease phenotypeLaura Groseanu, Violeta Bojinca, Tania Gudu, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Arthritis Care & Research|January 22, 2020
Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Maarten de Wit, et al.
Arthritis Research & Therapy|November 29, 2025
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trialsLaure Gossec, Andra Balanescu, Maria Antonietta D'Agostino, et al.
Rheumatology (Oxford, England)|July 24, 2020
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trialJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Maedica|May 4, 2017
Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma PatientsLaura Groseanu, Florian Berghea, Andra Balanescu, et al.
Maedica|May 4, 2017
Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma PatientsLaura Groseanu, Florian Berghea, Andra Balanescu, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
Pageof 6